statements

Medi-Caps Ltd.

BSE: 523144

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

25.33+0.3 (+1.32%)

23 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Medi-Caps Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	25.60	30.02	37.49	36.11	42.97	44.04	49.68	51.78	43.05	57.42	69.87	49.37	27.35	25.48	12.45	12.55
Cost of Operating Revenue	14.17	17.16	18.75	20.30	23.05	24.45	28.81	28.17	28.65	30.88	31.92	26.81	11.20	12.37	7.45	8.30
Gross Profit	11.43	12.86	18.74	15.81	19.92	19.59	20.87	23.62	14.40	26.53	37.95	22.56	16.14	13.11	5.00	4.25
Gross Margin	44.6	42.8	50.0	43.8	46.4	44.5	42.0	45.6	33.4	46.2	54.3	45.7	59.0	51.4	40.2	33.9
Total Operating Expenses	23.70	28.56	35.91	38.05	42.20	44.32	49.39	48.99	51.74	48.06	61.73	46.05	29.07	29.02	23.67	22.24
Operating Profit	1.91	1.45	1.58	-1.94	0.77	-0.28	0.28	2.79	-8.69	9.35	8.14	3.32	-1.72	-3.55	-11.22	-9.69
Operating Margin	7.4	4.8	4.2	-5.4	1.8	-0.6	0.6	5.4	-20.2	16.3	11.7	6.7	-6.3	-13.9	-90.1	-77.2
Financing Income/(Expense) - Net	0.47	-0.90	-1.09	-0.61	-0.03	-0.01	-0.01	-0.02	-0.02	-	1.29	1.60	-	-0.02	-0.01	-
Profit before Taxes	2.38	-0.26	-0.70	-1.26	1.42	1.72	1.35	5.50	-5.84	11.24	10.06	4.92	-1.25	-0.84	-3.02	-1.76
Income Taxes	1.46	1.15	1.08	0.80	0.56	0.35	0.20	0.12	0.01	-0.01	0.01	3.05	0.99	-0.27	0.01	0.01
Profit after Tax	1.53	-0.71	-1.30	-2.06	0.86	1.37	1.15	5.39	-5.85	11.13	10.08	1.76	-2.24	-0.57	-3.04	-1.78
PAT Margin	6.0	-2.4	-3.5	-5.7	2.0	3.1	2.3	10.4	-13.6	19.4	14.4	3.6	-8.2	-2.2	-24.4	-14.2
EPS - Basic - ex Extraordinary Items	1.22	-0.57	-1.04	-1.65	0.69	1.10	0.92	4.32	-4.69	11.14	8.05	1.50	-1.80	-0.46	-2.44	-1.41
EPS - Diluted - ex Extraordinary Items	1.22	-0.57	-1.04	-1.65	0.69	1.10	0.92	4.32	-4.69	11.14	8.08	1.50	-1.80	-0.46	-2.44	-1.41
EBIT	1.91	1.45	1.58	-1.94	0.77	-0.28	0.28	2.79	-8.69	9.35	8.14	3.32	-1.72	-3.55	-11.22	-9.69
EBITDA	3.66	3.57	3.65	-0.14	2.57	1.53	2.07	4.61	-6.86	11.21	10.05	5.13	-0.03	-1.83	-9.41	-7.87
EBITDA Margin	14.3	11.9	9.7	-0.4	6.0	3.5	4.2	8.9	-15.9	19.5	14.4	10.4	-0.1	-7.2	-75.6	-62.7

Balance Sheet

Abridged

Understanding Balance Sheet

Medi-Caps Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	26.84	30.73	36.92	26.74	31.68	33.05	37.10	42.00	33.13	52.67	66.69	60.20	60.01	53.44	47.02
Long-Term Investments	31.08	26.97	22.23	35.79	3.98	2.49	3.09	5.12	3.46	3.12	3.72	6.49	9.32	15.42	12.49
Property Plant & Equipment - Net	39.40	38.96	37.02	35.68	56.41	61.06	59.95	58.72	58.26	30.52	31.42	30.77	29.43	28.03	27.07
Total Non-Current Assets	71.13	71.70	65.03	72.19	61.35	64.32	63.80	64.61	62.08	62.15	63.66	65.78	67.27	71.99	68.44
Total Assets	97.97	102.43	101.94	98.93	93.03	97.38	100.91	106.61	95.21	114.82	130.35	125.99	127.28	125.42	115.46
Total Current Liabilities	5.57	4.67	5.86	5.92	9.46	6.76	9.09	9.15	3.37	9.27	13.20	5.17	5.26	3.10	2.71
Long Term Debt	0.31	6.27	8.87	10.51	0.08	0.09	-	0.06	-	-	-	-	-	-	-
Total Non-Current Liabilities	1.13	7.11	9.90	11.60	1.29	1.53	1.60	1.86	0.88	0.84	0.89	2.25	1.04	1.05	1.14
Total Liabilities	6.70	11.78	15.76	17.52	10.76	8.29	10.69	11.01	4.26	10.11	14.09	7.42	6.30	4.15	3.85
Total Shareholders' Equity	88.56	87.94	83.47	81.41	82.27	89.09	90.22	95.60	90.95	104.71	116.26	118.57	120.98	121.28	111.61
Minority Interest	2.72	2.72	2.72	-	-	-	-	-	-	-	-	-	-	-	-
Total Equity	91.28	90.65	86.18	81.41	82.27	89.09	90.22	95.60	90.95	104.71	116.26	118.57	120.98	121.28	111.61
Total Liabilities & Equity	97.97	102.43	101.94	98.93	93.03	97.38	100.91	106.61	95.21	114.82	130.35	125.99	127.28	125.42	115.46

Cash Flow

Abridged

Understanding Cash Flow Statement

Medi-Caps Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	2.52	0.66	0.38	-0.20	2.69	3.20	2.96	7.22	-2.93	15.60	13.46	4.12	4.09	2.00	-7.87
Working Capital - Increase/(Decrease)	5.38	-14.29	-1.59	7.26	-0.10	0.82	1.24	-1.26	7.56	-0.29	-6.44	-10.20	2.86	3.08	0.92
Net CF from Operating Activities	7.90	-13.63	-1.22	7.05	2.59	4.02	4.20	5.96	4.63	15.32	7.02	-6.08	6.94	5.08	-6.95
Capital Expenditures - Net	6.60	1.69	0.26	0.50	0.16	0.72	0.69	0.59	1.25	2.26	2.79	1.16	0.35	0.33	0.85
Net CF from Investing Activities	-7.49	6.13	1.26	-6.97	-1.47	2.57	-4.09	-5.75	-5.80	-9.70	-4.08	-2.56	-7.74	-4.99	7.04
Dividends Paid - Cash - Total	0.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	3.93	-	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-	5.96	-	-	-0.73	-9.69	0.08	-0.05	-0.06	-0.06	-	-	-	-	-
Net Cash Flow from Financing Activities	0.09	6.75	0.00	-	-0.73	-5.76	0.08	-0.05	-0.06	-0.06	-	-	-	-	-
Free Cash Flow to Equity	1.30	-9.37	-1.48	6.55	1.70	-6.39	3.60	5.32	3.32	13.00	4.23	-7.24	6.60	4.75	-7.80
Free Operating CF net dividend	0.83	-15.32	-1.48	6.55	2.43	3.30	3.51	5.38	3.38	13.06	4.23	-7.24	6.60	4.75	-7.80
Free Operating CF	1.30	-15.32	-1.48	6.55	2.43	3.30	3.51	5.38	3.38	13.06	4.23	-7.24	6.60	4.75	-7.80

Business Segment Analysis

Medi-Caps Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Medi-Caps Ltd.

Regional Segment Analysis

Medi-Caps Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Medi-Caps Ltd.

Historical Segment Analysis

Track how Medi-Caps Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Medi-Caps Ltd.

Frequently Asked Questions

What is the revenue of Medi-Caps Ltd.?

The latest trailing twelve month revenue of Medi-Caps Ltd. is ₹ 12.55 Cr, reflecting a 1-year growth of -42.89% and a 3-year CAGR of -33.85%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Medi-Caps Ltd.?

The latest trailing twelve month net profit (PAT) of Medi-Caps Ltd. is ₹ -3.04 Cr, with a 3-year earnings CAGR of -53.69%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Medi-Caps Ltd.?

The trailing twelve month EBITDA of Medi-Caps Ltd. is approximately ₹ -11.31 Cr (based on an operating margin of -90.12%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Medi-Caps Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Medi-Caps Ltd. is -2.44. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Medi-Caps Ltd.?

The debt-to-equity ratio of Medi-Caps Ltd. stands at 0.00. The interest coverage ratio is 999.00x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Medi-Caps Ltd.?

The estimated book value per share of Medi-Caps Ltd. is 89.50 (derived from a P/B ratio of 0.28 and market price of ₹ 25.33), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Medi-Caps Ltd.?

The trailing twelve month operating cash flow of Medi-Caps Ltd. is ₹ -6.95 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Medi-Caps Ltd. report consolidated or standalone financials?

Medi-Caps Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.